Precursor B-lymphoblastic leukemia

Precursor B-lymphoblastic leukemia (also known as B-ALL) is a type of cancer that originates in the lymphatic system, specifically in the B cells. It is a subtype of acute lymphoblastic leukemia (ALL), which is the most common type of cancer in children. However, B-ALL can also occur in adults.

Symptoms

The symptoms of B-ALL can vary, but they often include fatigue, fever, bruising or bleeding, bone pain, and lymphadenopathy (swollen lymph nodes). Other symptoms may include anemia, infection due to a weakened immune system, and weight loss.

Causes

The exact cause of B-ALL is unknown, but it is thought to involve a combination of genetic and environmental factors. Some studies have suggested that exposure to certain chemicals or radiation may increase the risk of developing B-ALL.

Diagnosis

Diagnosis of B-ALL typically involves a bone marrow biopsy, in which a small sample of bone marrow is removed and examined under a microscope. Other tests may include blood tests, imaging tests, and lumbar puncture.

Treatment

Treatment for B-ALL usually involves chemotherapy, which is often successful in children but less so in adults. Other treatment options may include radiation therapy, stem cell transplant, and targeted therapy.

Prognosis

The prognosis for B-ALL varies depending on a number of factors, including the patient's age, overall health, and the specific characteristics of the leukemia. However, with treatment, many people with B-ALL are able to achieve remission.

See also

• Acute lymphoblastic leukemia
• B cell
• Chemotherapy
• Radiation therapy

Precursor B-lymphoblastic leukemia Resources
Most recent articles Ongoing trials	Wikipedia